Sardanas, Elizabeth A.

HRN: 08-86-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2022
CEFUROXIME 1.5GM (VIAL)
06/06/2022
06/08/2022
IV
1.5 Ivt On Call To Or Then 750
Q8
TAHBSO
06/06/2022
CEFUROXIME 750MG (VIAL)
06/06/2022
06/08/2022
IV
750mg
Q8h
Post TAHBSO
06/06/2022
CEFUROXIME 1.5GM (VIAL)
06/06/2022
06/07/2022
IV
1.5g
Q8h X 2 Doses
S/P TAHBSO
Waiting Final Action 
06/07/2022
CEFUROXIME 500MG (TAB)
06/07/2022
06/14/2022
500MG
BID
7 Days
SP Exploratory Laparotomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: